Physician profile
Harry A Roach
NPI 1396745089
$2,930.18
in general payments reported to CMS, 2019-2025
17 companies · $478 in 2025
The $478 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $687 · 2021: $571 · 2022: $423 · 2023: $439 · 2024: $211 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,865.12 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $145.04 | 2025 | Enroute Transcarotid Stent |
| Baxter Healthcare | $144.30 | 2025 | |
| Neurocrine Biosciences, INC. | $125.78 | 2023 | Ingrezza |
| Pfizer INC. | $120.72 | 2019 | |
| Edwards Lifesciences Corporation | $113.31 | 2023 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $108.59 | 2021 | |
| Abbott Laboratories | $53.01 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.70 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $37.44 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.49 | 2024-2025 | Jardiance |
| Amgen INC. | $34.07 | 2024 | Repatha |
| Atricure, INC. | $31.24 | 2025 | Synergy Ablation System |
| Kiniksa Pharmaceuticals International, Plc | $19.43 | 2024 | Arcalyst |
| Stryker Corporation | $19.43 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $17.75 | 2024 | Opsumit, Uptravi |
| Ge Healthcare | $15.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Roach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.